D-0920-2022 Class II

Recalled by Olympia Compounding Pharmacy Dba Olympia Pharmacy — Orlando, FL

FDA drug recall D-0920-2022 was initiated by Olympia Compounding Pharmacy Dba Olympia Pharmacy on May 9, 2022 and is designated Class II. Reason for recall: Lack of assurance of sterility. Affected quantity: 1287 vials.

Recall Details

Product Type
Drugs
Report Date
Jun 1, 2022
Initiation Date
May 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1287 vials

Product Description

Bimix-3 Papaverine 30 mg/mL Phentolamine 3 mg/mL, Packaged as a) 2.5 mL Multi-Dose Vial, NDC73198-0027-03; b) 10 mL Multi-Dose Vial, NDC 73198-0027-10; Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835

Reason for Recall

Lack of assurance of sterility.

Distribution Pattern

Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

Code Information

Lots: J24F20, J24E20 BUD: 10/20/2022, B24G22-22, B24F22-22 BUD: 2/22/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0920-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.